Q4 2025 Beta Drugs Ltd Earnings Call Transcript

May 16, 2025 / 10:00 AM GMT

Release Date Price: ₹1786.9 (-5.11%)

Transcript

Key Points

Positve

Beta Drugs Ltd (NSE:BETA) reported a 24.14% increase in consolidated revenue, reaching INR 362 crores.
The company successfully launched 5 to 6 new molecules and concluded a significant audit from Mexico, enhancing its production capabilities.
Export sales grew by 72.69%, indicating a strong focus and potential in international markets.
The company achieved a milestone by crossing 100 crores in branded sales for the first time.
Beta Drugs Ltd (NSE:BETA) is planning to migrate to the main board between June and August, which could enhance its market presence.

Negative

Production was disrupted for 10 days due to an audit from Mexico, impacting potential revenue.
The cosmetology division is still a concern, although it is nearing break-even.
Financial costs increased due to provisions for convertible debentures issued during a preferential issue.
The company faces challenges in dossier registration timelines, which vary significantly across countries.
Despite growth, the domestic CDMO business is expected to grow only between 5% to 10% annually, indicating limited expansion in this segment.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BTAD.NS - Beta Drugs Ltd
Q4 2025 Beta Drugs Ltd Earnings Call
May 16, 2025 / 10:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to the H-2525 earnings conference call off. Beta Limited, Beta Drugs Limited, hosted by Philip Capital PCG test. As a reminder, all participant lines will be in the listen-only mood, and there will be an opportunity for you to ask questions after the presentation concludes.

Should you need assistance during the conference call, please signal an operator by pressing, then 0 on your touchtone phone. Please note that this conference is being recorded. I now hand the conference over to Mr. Sua from Philip Capital India Private Limited.

Thank you. I know what you saw.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-----

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.